News

We go over the latest tariff news and tell you how it is likely to shape the earnings picture, the trade deficit and the bond ...
Secretary of Health and Human Services Robert F. Kennedy Jr. received a blistering fact-check from a medical expert on ...
Ovarian Cancer Drugs Market grows as FDA, EMA fast-track advanced-stage therapies, boosting global approvals and innovation. Anurag Tiwari Orion Market Research Pvt Ltd + +91 91798 28694 email us here ...
The latest international Pfizer Inc news and views from Reuters - one of the world's largest news agencies ...
Donald Trump has threatened to introduce tariffs of up to 200pc on pharmaceutical imports in a bid to force more drugmakers ...
President Trump is pushing through with his tariff agenda, unveiling a new batch of letters to country leaders outlining ...
Global active pharmaceutical ingredients (API) market will reach $ 386.2 billion by 2032, growing by 6.4% annually over 2022-2032, driven by rising adoption of biologics in disease management, ...
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of all regional markets by country and split of each ...
Pfizer's Hympavzi has become the first once-weekly subcutaneous treatment for people living with severe haemophilia B in the EU that can be delivered via an autoinjector device at home.
Pfizer has joined the ranks of companies developing cancer drugs that target both PD-1 and VEGF – one of the hottest drug classes in oncology, via a $6 billion licensing deal with China's 3SBio.
President Trump is again amping up his trade threats, unveiling a new batch of letters to country leaders outlining tariffs ...